07.24.17
The 2021 version is ready and live online. Click here to review the latest Top Companies list!
Top 25 Pharma and Biopharma Companies (Based on 2016 Pharma/Biopharma Sales, in $U.S. Millions)
01. Pfizer $52,824
02. Novartis $48,518
03. Merck & Co. $39,807
04. Roche $38,369
05. GlaxoSmithKline $37,929
06. Sanofi $35,633
07. Johnson & Johnson $33,464
08. Gilead $30,390
09. AbbVie $25,638
10. AstraZeneca $23,002
11. Amgen $22,991
12. Teva $21,903
13. Eli Lilly & Co. $21,222
14. Bristol-Myers Squibb $19,427
15. Bayer $17,300
16. Boehringer Ingelheim $16,699
17. Novo Nordisk $15,841
18. Merck KGaA $15,828
19. Takeda $15,565
20. Allergan $14,570
21. Biogen $11,449
22. Shire $11,397
23. Celgene $11,229
24. Mylan $11,077
25. Otsuka $10,240
Contributors
Editor: Tim Wright
Associate Editor: Kristin Brooks
All profiles compiled by Tim Wright, except Gilead, Amgen, Boehringer Ingelheim, Biogen, Celgene and Otsuka, by Kristin Brooks Pipeline/revenue information compiled by Kristin Brooks
*Profile information is sourced from each company’s annual report along with press releases distributed throughout the year. Pharma/biopharmaceutical sales are the primary factor in the rankings, however results may include animal heath sales where applicable and other smaller division sales. Large medical device, diagnostics, and consumer care division revenues have been excluded from the rankings.
Top 25 Pharma and Biopharma Companies (Based on 2016 Pharma/Biopharma Sales, in $U.S. Millions)
01. Pfizer $52,824
02. Novartis $48,518
03. Merck & Co. $39,807
04. Roche $38,369
05. GlaxoSmithKline $37,929
06. Sanofi $35,633
07. Johnson & Johnson $33,464
08. Gilead $30,390
09. AbbVie $25,638
10. AstraZeneca $23,002
11. Amgen $22,991
12. Teva $21,903
13. Eli Lilly & Co. $21,222
14. Bristol-Myers Squibb $19,427
15. Bayer $17,300
16. Boehringer Ingelheim $16,699
17. Novo Nordisk $15,841
18. Merck KGaA $15,828
19. Takeda $15,565
20. Allergan $14,570
21. Biogen $11,449
22. Shire $11,397
23. Celgene $11,229
24. Mylan $11,077
25. Otsuka $10,240
Contributors
Editor: Tim Wright
Associate Editor: Kristin Brooks
All profiles compiled by Tim Wright, except Gilead, Amgen, Boehringer Ingelheim, Biogen, Celgene and Otsuka, by Kristin Brooks Pipeline/revenue information compiled by Kristin Brooks
*Profile information is sourced from each company’s annual report along with press releases distributed throughout the year. Pharma/biopharmaceutical sales are the primary factor in the rankings, however results may include animal heath sales where applicable and other smaller division sales. Large medical device, diagnostics, and consumer care division revenues have been excluded from the rankings.